Brooks McNamara
Joined April 2024
0 stories
Bio
selleck C6-ceramide therapy inhibits the particular proangiogenic action regarding a number of myeloma exosomes through the miR-29b/Akt pathway.
selleck C6-ceramide therapy inhibits the particular proangiogenic action regarding a number of myeloma exosomes through the miR-29b/Akt pathway.